Association between SGLT2 inhibitor use and heart failure outcomes in anthracycline-exposed patients: a meta-analysis
Anthracyclines are among the chemotherapeutic agents most strongly associated with cancer therapy–related cardiac dysfunction (CTRCD) and represent the class with the highest incidence of cardiotoxicity, affecting up to one third of exposed patients. Anthracycline-induced cardiotoxicity frequently manifests as He...